PL353992A1 - Koniugaty 4-benzyloaminochinoliny z kwasem żółciowKoniugaty 4-benzyloaminochinoliny z kwasem żółciowym i ich heteroanalogi, sposób ich wytwarzania, śrym i ich heteroanalogi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosodki lecznicze zawierające te związki i ich zastosowanieowanie - Google Patents

Koniugaty 4-benzyloaminochinoliny z kwasem żółciowKoniugaty 4-benzyloaminochinoliny z kwasem żółciowym i ich heteroanalogi, sposób ich wytwarzania, śrym i ich heteroanalogi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosodki lecznicze zawierające te związki i ich zastosowanieowanie

Info

Publication number
PL353992A1
PL353992A1 PL00353992A PL35399200A PL353992A1 PL 353992 A1 PL353992 A1 PL 353992A1 PL 00353992 A PL00353992 A PL 00353992A PL 35399200 A PL35399200 A PL 35399200A PL 353992 A1 PL353992 A1 PL 353992A1
Authority
PL
Poland
Prior art keywords
compounds
benzylaminoquinoline
heteroanalogues
conjugates
producing
Prior art date
Application number
PL00353992A
Other languages
English (en)
Inventor
ArminHofmeister Armin Hofmeister
EugenFalk Eugen Falk
Heinz-WernerKleemann Heinz-Werner Kleemann
Hans-WilliJansen Hans-Willi Jansen
MartinBickel Martin Bickel
Original Assignee
Aventis Pharma Deutschland Gmbhaventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999145385 external-priority patent/DE19945385A1/de
Priority claimed from DE2000128193 external-priority patent/DE10028193A1/de
Application filed by Aventis Pharma Deutschland Gmbhaventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbhaventis Pharma Deutschland Gmbh
Publication of PL353992A1 publication Critical patent/PL353992A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00353992A 1999-09-22 2000-09-06 Koniugaty 4-benzyloaminochinoliny z kwasem żółciowKoniugaty 4-benzyloaminochinoliny z kwasem żółciowym i ich heteroanalogi, sposób ich wytwarzania, śrym i ich heteroanalogi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosodki lecznicze zawierające te związki i ich zastosowanieowanie PL353992A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999145385 DE19945385A1 (de) 1999-09-22 1999-09-22 Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2000128193 DE10028193A1 (de) 2000-06-09 2000-06-09 Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente
PCT/EP2000/008691 WO2001021642A1 (de) 1999-09-22 2000-09-06 4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung

Publications (1)

Publication Number Publication Date
PL353992A1 true PL353992A1 (pl) 2003-12-15

Family

ID=26005994

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353992A PL353992A1 (pl) 1999-09-22 2000-09-06 Koniugaty 4-benzyloaminochinoliny z kwasem żółciowKoniugaty 4-benzyloaminochinoliny z kwasem żółciowym i ich heteroanalogi, sposób ich wytwarzania, śrym i ich heteroanalogi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosodki lecznicze zawierające te związki i ich zastosowanieowanie

Country Status (26)

Country Link
US (1) US6339077B1 (pl)
EP (1) EP1218401B1 (pl)
JP (1) JP4833471B2 (pl)
KR (1) KR20030010575A (pl)
CN (1) CN1158299C (pl)
AT (1) ATE269352T1 (pl)
AU (1) AU779412B2 (pl)
BR (1) BR0014233A (pl)
CA (1) CA2385445A1 (pl)
CZ (1) CZ2002992A3 (pl)
DE (1) DE50006842D1 (pl)
DK (1) DK1218401T3 (pl)
EE (1) EE200200143A (pl)
ES (1) ES2218222T3 (pl)
HK (1) HK1049169B (pl)
HR (1) HRP20020238A2 (pl)
HU (1) HUP0203045A3 (pl)
IL (1) IL148739A0 (pl)
NO (1) NO20021337L (pl)
NZ (1) NZ517899A (pl)
PL (1) PL353992A1 (pl)
PT (1) PT1218401E (pl)
RU (1) RU2247125C2 (pl)
SK (1) SK3862002A3 (pl)
WO (1) WO2001021642A1 (pl)
YU (1) YU19302A (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
WO2010111348A1 (en) * 2009-03-24 2010-09-30 Abbott Laboratories Process for preparing antiviral compound
SG184156A1 (en) * 2010-04-02 2012-10-30 Senomyx Inc Sweet flavor modifier
CA2841012C (en) 2011-08-12 2019-07-30 Senomyx, Inc. Sweet flavor modifier
MX2017005931A (es) 2014-11-07 2017-06-30 Senomyx Inc Acidos 4-amino-5- (ciclohexiloxi) quinolina-3-carboxilicos sustituidos como modificadores del sabor dulce.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
TW289021B (pl) * 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
AU7552198A (en) * 1997-06-11 1998-12-30 Sankyo Company Limited Benzylamine derivatives

Also Published As

Publication number Publication date
JP4833471B2 (ja) 2011-12-07
WO2001021642A1 (de) 2001-03-29
EP1218401A1 (de) 2002-07-03
DK1218401T3 (da) 2004-10-04
EP1218401B1 (de) 2004-06-16
JP2003510255A (ja) 2003-03-18
CA2385445A1 (en) 2001-03-29
CN1158299C (zh) 2004-07-21
HRP20020238A2 (en) 2004-04-30
IL148739A0 (en) 2002-09-12
NZ517899A (en) 2004-03-26
AU7515600A (en) 2001-04-24
HUP0203045A3 (en) 2004-06-28
PT1218401E (pt) 2004-10-29
SK3862002A3 (en) 2003-01-09
YU19302A (sh) 2004-11-25
ATE269352T1 (de) 2004-07-15
HUP0203045A2 (hu) 2003-01-28
ES2218222T3 (es) 2004-11-16
CZ2002992A3 (cs) 2002-06-12
RU2247125C2 (ru) 2005-02-27
US6339077B1 (en) 2002-01-15
NO20021337D0 (no) 2002-03-18
DE50006842D1 (de) 2004-07-22
BR0014233A (pt) 2002-05-21
HK1049169B (zh) 2005-04-22
HK1049169A1 (en) 2003-05-02
KR20030010575A (ko) 2003-02-05
AU779412B2 (en) 2005-01-20
EE200200143A (et) 2003-04-15
CN1374968A (zh) 2002-10-16
NO20021337L (no) 2002-05-15

Similar Documents

Publication Publication Date Title
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
WO2004037807A3 (en) Medicinal arylethanolamine compounds
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
PT1427708E (pt) Derivados amino-ftalazinona activos como inibidors de cinase, processo para a sua preparação e composições farmacêuticas contendo-os
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
HK1065483A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
DE602004011966D1 (en) Heterocyclylverbindungen
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
WO2002070515A3 (en) Chromane derivatives, process for their preparation and their use as antitumor agents
HRP20020238A2 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
IL148250A0 (en) Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
AU2001266019A1 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
MY126998A (en) Substituted pyrroles.
EP1232748A4 (en) SUBSTITUTED NITROBENZENE-LIKE DERIVATIVE PRODUCT AS A MEDICINAL PRODUCT OR OTHER EFFICIENT PRODUCTS
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
HK1097548A1 (en) Novel indeno

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)